CSL Limited (ASX: CSL) shareholders will have something to cheer about today as the company pays out its latest dividend.
The biotherapeutics giant is set to reward eligible investors with an unfranked interim dividend of US$1.04 (AU$1.42) per share.
At Tuesday's market close, the CSL share price finished 0.31% higher at $268.53.
For context, the S&P/ASX 200 Index (ASX: XJO) also climbed yesterday with a 0.19% gain to 7,527.90 points.
Let's look at all the details regarding the company's dividend.
CSL pays out interim dividend
CSL reported mixed numbers across key metrics in its results for the first half of the 2022 financial year.
In summary, total revenue rose 5.3% to US$6,041 million over the prior corresponding period. This was driven by an 18% lift in Seqirus revenue to US$1,592 million, but CSL Behring revenue slightly declined by 2% to US$4,216 million.
On the bottom line, CSL recorded a 2.8% fall in net profit after tax (NPAT) to US$1,760 million.
Management noted that the result was in line with expectations caused by a challenging environment from the global COVID pandemic.
Nonetheless, the board elected to maintain its interim dividend on the previous year's first half of US$1.04 per share.
Based on the current share price, CSL is trailing on a forecast dividend yield of 0.59%.
CSL share price snapshot
While the CSL share price has notched up in the past month by 4%, it is still down 7% year to date.
Looking slightly further back, the company's shares reached a 52-week high of $319.78 in late November before its steep dive.
CSL has a price-to-earnings (P/E) ratio of 52.86 and commands a market capitalisation of roughly $129.35 billion.
